Clarity should be prescribed only after a clinician reviews the patient’s neurologic, psychiatric, and medication history because the blend contains multiple neuroactive and recovery-focused peptides. Particular attention should be paid to other medications that affect mood, anxiety, sleep, or attention, as well as concurrent peptide therapies. Because Clarity is a compounded combination, long-term human safety data for the exact formula are not available. Possible issues can include headache, changes in sleep, mood or stimulation, gastrointestinal symptoms, or local irritation from the troche.